AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06045897 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Voice recording
Description: A double channel audio recorder will be used during 30 min to assess voice characteristics of all subjects.
Study NCT04996524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epidural analgesia
Description: Patients recieving epidural analgesia instead of systemic analgesia for acute pain in the intensive care unit
Study NCT05213676 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Inhaled Nitric Oxide (iNO) use
Description: The center will use iNO per their usual protocol in the initial resuscitation period (defined as birth through stabilization and CDH repair). No center will alter any component of their standard clinical practice guideline or protocol governing CDH care.
Study NCT05213676 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: De-implementation of Inhaled Nitric Oxide (iNO) use
Description: The center will stop using iNO in the initial resuscitation period (defined as birth through stabilization and CDH repair).
Study NCT05960786 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Otoband Experimental
Description: Participants will be randomly assigned to use the Otoband to determine effectiveness in providing temporary relief to symptoms of vertigo.
Study NCT05960786 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Otoband Sham
Description: Participants will be randomly assigned to use the Otoband sham to determine effectiveness in providing temporary relief to symptoms of vertigo.
Study NCT05948319 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Doppler ultrasonography
Description: Doppler study was performed in all cases. perinatal outcomes were evaluated.
Study NCT05490498 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collection of breast milk
Description: Collection of breast milk through a sterilized breastfeeding device. Once the collection is completed, the milk will be transferred to a sterile jar provided in a dedicated survey package for transport to the laboratory.
Study NCT05423145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: self-administered acupressure
Description: The acupressure intervention is self-administered. The intervention group receives an app that instructs them on how to perform a stimulating acupressure protocol, consisting of six acupoints with four of the acupoints performed on both the left and the right sides of the body for a total of ten points. Each of the ten acupoints is to be stimulated for 3 minutes per point for a total treatment time of 30 minutes daily for 6 weeks.
Study NCT04936256 — intervention group
Intervention type: DEVICE
Intervention: Clareon
Description: Clareon monofocal intraocular lens (IOL)
Study NCT04023604 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Controlled diet with beef raised without antibiotics
Description: The controlled diet with beef raised without antibiotics will follow the Dietary Guidelines for American's recommendations. All foods and beverages will be provided during intervention to achieve the desired eating pattern. Beef included in this diet were raised without antibiotics.
Study NCT04023604 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled diet with beef produced in conventional systems
Description: The controlled diet with beef raised without antibiotics will follow the Dietary Guidelines for American's recommendations. All foods and beverages will be provided during intervention to achieve the desired eating pattern. Beef included in this diet were raised with antibiotics.
Study NCT05421091 — intervention group
Intervention type: OTHER
Intervention: Asciminib
Description: Prospective observational study. There is no treatment allocation. Patients prescribed with asciminib are eligible to enroll into this study.
Study NCT05972876 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blood flow restriction training
Description: BFR will be achieved using an automatic personalized tourniquet system (MAD-UP, Angers, France) designed to automatically calculate limb occlusion pressure
Study NCT05972876 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance training
Description: Resistance training will be performed without any blood flow restriction
Study NCT05174897 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: emotional liberation technique
Description: experimental group; The child, to whom an intravenous catheter will be applied, is placed on a stretcher. pain ve score fear will be evaluated before the procedure. Then, the emotional liberation technique (EFT) will be applied for 10 minutes and an intravenous catheter will be applied to evaluate the pain and fear scores during and after the procedure.
Study NCT05544916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XC221
Description: 200 mg/day, for 5 days
Study NCT05544916 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 tablets/day, for 5 days
Study NCT06472063 — intervention group
Intervention type: OTHER
Intervention: pre- or perioperative treatment and D2 gastrectomy
Description: pre- or perioperative treatment and D2 gastrectomy
Study NCT05467280 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online HIIT Intervention
Description: They will be given HIIT exercise video sessions twice a week for 6 months, through a mobile application where they will also be given nutritional and health advice, webinars and challenges.
Study NCT05770856 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Metagenomic sequencing
Description: Samples shall be submitted to high throughput sequencing using both illumine MiSeq and Oxford Nanopore Technologies.
Study NCT05489510 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: Pulsed or continuous lighting
Description: The cross-linking procedures will be performed on an outpatient basis using the PXL Platinum 330 System (UVA light source and riboflavin solution).
Study NCT05031806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iNexin™ (0.08% aCT1)
Description: 36 eligible subjects will be randomized to Vehicle or one of three concentrations of iNexin™ to be administered bilaterally BID for 15 days (from Visit 2 to the evening of Visit 4). Subjects will be randomized 2:1 for each active concentration to Vehicle.randomized 7:3 for each active concentration to Vehicle.
Study NCT05031806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iNexin™ (0.4% aCT1)
Description: 36 eligible subjects will be randomized to Vehicle or one of three concentrations of iNexin™ to be administered bilaterally BID for 15 days (from Visit 2 to the evening of Visit 4). Subjects will be randomized 2:1 for each active concentration to Vehicle.
Study NCT05031806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iNexin™ (2.0% aCT1)
Description: 36 eligible subjects will be randomized to Vehicle or one of three concentrations of iNexin™ to be administered bilaterally BID for 15 days (from Visit 2 to the evening of Visit 4). Subjects will be randomized 2:1 for each active concentration to Vehicle.
Study NCT05031806 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle (eye drop formulation without aCT1)
Description: 36 eligible subjects will be randomized to Vehicle or one of three concentrations of iNexin™ to be administered bilaterally BID for 15 days (from Visit 2 to the evening of Visit 4). Subjects will be randomized 2:1 for each active concentration to Vehicle.~During a 7-day study run-in period prior to randomization, all subjects will receive Vehicle eye drops (Vehicle) bilaterally BID (from Visit 1 to the evening before Visit 2).
Study NCT04933968 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ALVR106
Description: Infusion, visually identical to placebo
Study NCT04933968 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Infusion, visually identical to ALVR106
Study NCT05228938 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VNOTES
Description: vaginal Natural Orifice Transluminal Endoscopic Surgery approach for Elective bilateral salpingectomy or Salpingo-oophorectomy
Study NCT05228938 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: laparoscopic
Description: laparoscopic Surgery approach for Elective bilateral salpingectomy or Salpingo-oophorectomy
Study NCT06087029 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TEVAR
Description: Thoracic endovascular aortic repair
Study NCT06087029 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Guideline directed medical therapy and surveillance of dissection
Description: Routine clinical care with suggested antihypertensive therapy and cardiovascular risk factor reduction as per appropriate cardiovascular guidelines.
Study NCT06087029 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Guideline directed medical therapy and surveillance of dissection
Description: Routine clinical care with suggested antihypertensive therapy and cardiovascular risk factor reduction as per appropriate cardiovascular guidelines.
Study NCT05364125 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Olfactory Training
Description: Four aromatic substances will be used (Citrus limon, Eucalyptus radiata, Pelargonium graveolens, Juniperus virginiana)
Study NCT05364125 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Normal Saline will be used
Study NCT05243836 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: S.T.O.P® F2
Description: Ocufilcon D, 55% water
Study NCT05243836 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: S.T.O.P® DT
Description: Ocufilcon D, 55% water
Study NCT05243836 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MiSight®
Description: Omafilcon A (60% water)
Study NCT05930457 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2.5-3.5mCi 64Cu-FAPI-XT117
Description: 64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 2.5-3.5mCi 64Cu-FAPI-XT117 injection.
Study NCT05564936 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: ME&MG mobile application
Description: ME\&MG is a standalone software (digital solution) running on patients smartphones, connected to a web portal for physicians. It is intended to be used as an unsupervised digital self-assessment tool for the monitoring of disabilities in patients living with MG.
Study NCT05564936 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ME&MG mobile application
Description: ME\&MG is a standalone software (digital solution) running on patients smartphones, connected to a web portal for physicians. It is intended to be used as an unsupervised digital self-assessment tool for the monitoring of disabilities in patients living with MG.
Study NCT05450731 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise based cardiac rehabilitation program
Description: 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.
Study NCT05890846 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active iTBS
Description: Each participant will receive 1800 pulse active iTBS (100% RMT) in each session, 3 sessions per day, 5 days per week for 12 weeks.
Study NCT05890846 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham iTBS
Description: Each participant will receive 1800 pulse sham iTBS (100% RMT) in each session, 3 sessions per day, 5 days per week for 12 weeks.
Study NCT05890846 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: traditional 1on1 course
Description: Between every two iTBS sessions, the participant will receive a personalized 30-minutes one-on-one behavioral course, 2 courses per day, 5 days per week for 12 weeks.
Study NCT05890846 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: traditional 1on1 course
Description: Between every two iTBS sessions, the participant will receive a personalized 30-minutes one-on-one behavioral course, 2 courses per day, 5 days per week for 12 weeks.
Study NCT05930457 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3.5-4.5mCi 64Cu-FAPI-XT117
Description: 64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 3.5-4.5mCi 64Cu-FAPI-XT117 injection.
Study NCT05930457 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4.5-5.5mCi 64Cu-FAPI-XT117
Description: 64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 4.5-5.5mCi 64Cu-FAPI-XT117 injection.
Study NCT05841641 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser Bandage
Description: The Diode Laser will create a biological bandage at a wavelength of 810 nm, set at 5W in continuous-wave mode, applied via a 400-µm optical fibre.
Study NCT05841641 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hemostatic agent with surgical stent
Description: Following graft harvesting, the donor site was secured with a hemostatic agent and protected with a palatal stent
Study NCT04737954 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Venepuncture
Description: Venous blood draw
Study NCT04737954 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Fingerstick
Description: Capillary blood draw
Study NCT06139939 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Double layer technique
Description: Double layer technique for alveolar ridge augmentation (first layer autograft followed by xenograft second layer).
Study NCT06139939 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Double layer technique
Description: Double layer technique for alveolar ridge augmentation (first layer autograft followed by xenograft second layer).
Study NCT04970433 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Description: Acupuncture at Hegu (LI4), Neiguan (PC6), Zusanli (ST36), Sanyinjiao (SP6) and Sishencong (EX-HN1). Electrical stimulation with a pair of electrodes connecting on LI4/PC6 and ST36/SP6.
Study NCT04970433 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laser acupuncture (LA)
Description: The laser applies to each point for 40 seconds, which delivers 3 J of energy at each of the acupoints as those in electroacupuncture group.
Study NCT04970433 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham laser acupuncture (SLA)
Description: The laser device without any laser output applies on the acupoints the same as those in the LA group.
Study NCT05498779 — intervention group
Intervention type: PROCEDURE
Intervention: Ablation therapy
Description: Radiofrequency or microwave ablation
Study NCT06633822 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Digital planning
Description: The digital methodology will consist of obtaining a digital scan and a computed tomography (CBCT) that will be aligned using a digital program for the elaboration of a digital wax-up and fabrication of a printed surgical template.
Study NCT06633822 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Analogic planning
Description: The analog wax-up will be elaborated based on a silicone impression and periapical radiographs with parallel technique, which will allow us to elaborate an essix-type surgical splint.
Study NCT06431087 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness course
Description: Online or in presence Information on Mindfulness, healthy diet and exercise.
Study NCT04853212 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Biopsy during recto-coloscopy
Study NCT04853212 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Biopsy
Description: Biopsy during recto-coloscopy
Study NCT05956496 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Allograft Material ADM-S
Description: A piece of the allograft material (ADM-D) will be hydrated per the manufacturers guidelines and adapted to the recipient area after reflection of a partial thickness flap. The flap will be coronally advanced to completely cover the graft material per standard care for this procedure.
Study NCT05956496 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Allograft Material ADM-D
Description: A piece of the allograft material (ADM-S) will be hydrated per the manufacturers guidelines and adapted to the recipient area after reflection of a partial thickness flap. The flap will be coronally advanced to completely cover the graft material per standard care for this procedure.
Study NCT04946006 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin
Description: Oxytocin will be prepared in a 1L bag of Ringer's lactate, to be infused at a rate of 125 ml/h.
Study NCT06247020 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Supplementation with sodium- butyrrate
Description: Oral supplementation with sodium butyrrate capsules
Study NCT06247020 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral supplementation with placebo capsules
Study NCT04932577 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation
Description: All participant will receive three applications of either FMT or placebo and afterwards followed for 1 year.
Study NCT04932577 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06632665 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: transcutaneous vagus nerve stimulation+virtual reality+routine physical therapy
Description: Transcutaneous vagus nerve stimulation Location The left auricular branch vagus nerve will be stimulated by the modified dot -like electrodes will be fitted to the cymba conchae.frequency:Stimulation perform for 30 minutes per day for 4 weeks .~duration 600 pulses (intratrain pulse) frequency =20 Hz ; Pulse duration =0.3ms ,lasting 30 seconds each time ,stimulating once every 5 minutes
Study NCT06632665 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: transcutaneous vagus nerve stimulation+routine physical therapy
Description: Transcutaneous vagus nerve stimulation Location The left auricular branch vagus nerve will be stimulated by the modified dot -like electrodes will be fitted to the cymba conchae.Stimulation perform for 30 minutes per day for 4 weeks .~Routine physical therapy Stretching Areas :upper chest ,neck flexors ,shoulder flexor and adductors ,elbow and wrist flexors 10 minute per session,and stretches will held for 10s -30swith four repetition of each.30 minutes per day for 4 weeks Upper extremity Proprioception ,coordination,speed and agility increase such as followReach and grasp Handle turning simulated eating task Inserting object Opening bottle strenghtening exercise Muscles biceps brachii brachialis Coracobrachialis triceps brachii wrist extensors 10 minute per session for 4 weeks
Study NCT06224465 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: aerobic exercises
Description: Antiaging diet instruction :Be aware of the amount of calories, Reduce overall fat and sugar intake, Drink at least 10 glasses of water every day in order to remain healthy.~d. Eat a variety of complex carbohydrates and vegetables instead of bread, rice, and corn.
Study NCT06224465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercises
Description: Antiaging diet instruction :Be aware of the amount of calories, Reduce overall fat and sugar intake, Drink at least 10 glasses of water every day in order to remain healthy.~d. Eat a variety of complex carbohydrates and vegetables instead of bread, rice, and corn.
Study NCT04916444 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: rTMS
Description: repetitive transcranial magnetic stimulation is a painless, noninvasive form of neurostimulation. This study uses an accelerated protocol in which the neurostimulation pulses are delivered in 4 sessions per day over 4 consecutive days (16 total sessions). Active or sham rTMS will be provided at 9 weeks following botox injections.
Study NCT04916444 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: rTMS
Description: repetitive transcranial magnetic stimulation is a painless, noninvasive form of neurostimulation. This study uses an accelerated protocol in which the neurostimulation pulses are delivered in 4 sessions per day over 4 consecutive days (16 total sessions). Active or sham rTMS will be provided at 9 weeks following botox injections.
Study NCT06574360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S1RA plus NMDAE
Description: Use of an S1R agonist plus an NMDA enhancer for the treatment of treatment-resistant schizophrenia.
Study NCT06574360 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: S1RA plus Placebo Cap
Description: Use of an S1R agonist plus placebo as a comparator
Study NCT04709211 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Facia Iliaca block
Description: patients will receive Ultrasound-guided Facia Iliaca block using 50 ml 0f Bupivacaine 0.25%
Study NCT04709211 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anterior Quadratus Lumbroum block
Description: patients will receive Ultrasound-guided Anterior Quadratus Lumbroum block using 50 ml 0f Bupivacaine 0.25%
Study NCT04709211 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine
Description: bupivacaine
Study NCT05347212 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given by IV